A Clinical Trial to Compare Atezolizumab plus Bevacizumab with Sorafenib in Patients with Untreated Advanced Hepatocellular Carcinoma (IMbrave150)

A Study of Atezolizumab in Combination With Bevacizumab Compared With Sorafenib in Patients With Untreated Locally Advanced or Metastatic Hepatocellular Carcinoma (IMbrave150) [IMbrave150]

Cancer
Hepatocellular Carcinoma (HCC)

Results
Download
Print

Study results

LPS YO40245 IMbrave150 Final Results May 2020 English (PDF, 1.6 MB)

LPS YO40245 IMbrave150 Final Results May 2020 Canada French (PDF, 0.6 MB)

LPS YO40245 IMbrave150 Final Results August 2020 Taiwan Chinese (PDF, 1.3 MB)

LPS YO40245 IMbrave150 Final Results August 2020 South Korea Korean (PDF, 0.6 MB)

LPS YO40245 IMbrave150 Final Results August 2020 Hong Kong Chinese (PDF, 0.7 MB)

LPS YO40245 IMbrave150 Final Results May 2020 German (PDF, 0.6 MB)

What is Clinical Research?

In clinical research, volunteers, researchers, and medical professionals work together toward a shared goal: better treatment outcomes for patients. Clinical trials are vital to their process. They are carefully designed and follow approved protocols.

A Clinical Trial to Compare Atezolizumab plus Bevacizumab with Sorafenib in Patients with Untreated Advanced Hepatocellular Carcinoma (IMbrave150)

Study results

LPS YO40245 IMbrave150 Final Results May 2020 English (PDF, 1.6 MB)

LPS YO40245 IMbrave150 Final Results May 2020 Canada French (PDF, 0.6 MB)

LPS YO40245 IMbrave150 Final Results August 2020 Taiwan Chinese (PDF, 1.3 MB)

LPS YO40245 IMbrave150 Final Results August 2020 South Korea Korean (PDF, 0.6 MB)

LPS YO40245 IMbrave150 Final Results August 2020 Hong Kong Chinese (PDF, 0.7 MB)

LPS YO40245 IMbrave150 Final Results May 2020 German (PDF, 0.6 MB)

What is Clinical Research?

For the latest version of this information please go to www.forpatients.roche.com

Directly contact Roche for questions

Contact the hospital directly

Thank you

Something went wrong

Request a call back

Find participating medical centers and current study status in each of them

A Clinical Trial to Compare Atezolizumab plus Bevacizumab with Sorafenib in Patients with Untreated Advanced Hepatocellular Carcinoma (IMbrave150)

For the latest version of this information please go to www.forpatients.roche.com